APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Asthma Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025185 pages

Choose your research edition.

Industry ResearchAsthma Treatment Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Treatment Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Asthma Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Treatment Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Treatment Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Asthma Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Asthma Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Asthma Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Treatment Drugs include Teva, Sanofi, Merck, GlaxoSmithKline, AstraZeneca, Roche & Novartis and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Treatment Drugs Segment by Company

Teva

Sanofi

Merck

GlaxoSmithKline

AstraZeneca

Roche & Novartis

Boehringer Ingelheim

Asthma Treatment Drugs Segment by Type

Long-term Control Medications

Quick-relief Medications (Rescue Medications)

Medications for Allergy-induced Asthma

Asthma Treatment Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Asthma Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Asthma Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Asthma Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Asthma Treatment Drugs Industry Trends Table 2. Asthma Treatment Drugs Industry Drivers Table 3. Asthma Treatment Drugs Industry Opportunities and Challenges Table 4. Asthma Treatment Drugs Industry Restraints Table 5. Global Asthma Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Asthma Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Asthma Treatment Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Asthma Treatment Drugs Sales Market Share by Manufacturers Table 9. Global Asthma Treatment Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Asthma Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Asthma Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Asthma Treatment Drugs Manufacturers, Product Type & Application Table 13. Global Asthma Treatment Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Long-term Control Medications Table 17. Major Manufacturers of Quick-relief Medications (Rescue Medications) Table 18. Major Manufacturers of Medications for Allergy-induced Asthma Table 19. Global Asthma Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Asthma Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Asthma Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Asthma Treatment Drugs Sales Market Share by Type (2021-2026) Table 23. Global Asthma Treatment Drugs Sales Market Share by Type (2027-2032) Table 24. Global Asthma Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Asthma Treatment Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Asthma Treatment Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Asthma Treatment Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Asthma Treatment Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Retail Pharmacy Table 30. Major Manufacturers of Online Pharmacy Table 31. Major Manufacturers of Hospital Pharmacy Table 32. Global Asthma Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Asthma Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 34. Global Asthma Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 35. Global Asthma Treatment Drugs Sales Market Share by Application (2021-2026) Table 36. Global Asthma Treatment Drugs Sales Market Share by Application (2027-2032) Table 37. Global Asthma Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Asthma Treatment Drugs Revenue by Application (2021-2026) & (K Units) Table 39. Global Asthma Treatment Drugs Revenue by Application (2027-2032) & (K Units) Table 40. Global Asthma Treatment Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Asthma Treatment Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Asthma Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Asthma Treatment Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Asthma Treatment Drugs Sales Market Share by Region (2021-2026) Table 45. Global Asthma Treatment Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Asthma Treatment Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Asthma Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 49. North America Asthma Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 50. Europe Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Asthma Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 52. Europe Asthma Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Asthma Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Asthma Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Asthma Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Asthma Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Asthma Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Asthma Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Asthma Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Asthma Treatment Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Asthma Treatment Drugs Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Asthma Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Asthma Treatment Drugs Product Portfolio Table 68. Teva Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Asthma Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi Asthma Treatment Drugs Product Portfolio Table 73. Sanofi Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Asthma Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Asthma Treatment Drugs Product Portfolio Table 78. Merck Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Asthma Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Asthma Treatment Drugs Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Asthma Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. AstraZeneca Asthma Treatment Drugs Product Portfolio Table 88. AstraZeneca Recent Development Table 89. Roche & Novartis Company Information Table 90. Roche & Novartis Business Overview Table 91. Roche & Novartis Asthma Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Roche & Novartis Asthma Treatment Drugs Product Portfolio Table 93. Roche & Novartis Recent Development Table 94. Boehringer Ingelheim Company Information Table 95. Boehringer Ingelheim Business Overview Table 96. Boehringer Ingelheim Asthma Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Boehringer Ingelheim Asthma Treatment Drugs Product Portfolio Table 98. Boehringer Ingelheim Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Asthma Treatment Drugs Distributors List Table 102. Asthma Treatment Drugs Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Asthma Treatment Drugs Product Image Figure 2. Global Asthma Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Treatment Drugs Sales (2021-2032) & (K Units) Figure 5. Global Asthma Treatment Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Asthma Treatment Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Long-term Control Medications Image Figure 9. Quick-relief Medications (Rescue Medications) Image Figure 10. Medications for Allergy-induced Asthma Image Figure 11. Global Asthma Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Asthma Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Asthma Treatment Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Asthma Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Asthma Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Asthma Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Hospital Pharmacy Image Figure 20. Global Asthma Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Asthma Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Asthma Treatment Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Asthma Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Asthma Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Asthma Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Asthma Treatment Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Asthma Treatment Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Asthma Treatment Drugs Sales Market Share by Country (2021-2032) Figure 40. China Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Asthma Treatment Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Asthma Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Asthma Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Asthma Treatment Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Asthma Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Asthma Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Asthma Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Asthma Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asthma Treatment Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Asthma Treatment Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Long-term Control Medications
  • Quick-relief Medications (Rescue Medications)
  • Medications for Allergy-induced Asthma
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Teva
  • Sanofi
  • Merck
  • GlaxoSmithKline
  • AstraZeneca
  • Roche & Novartis
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Asthma Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Asthma Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Asthma Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Asthma Treatment Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Asthma Treatment Drugs Market Dynamics
  1. 2.1 Asthma Treatment Drugs Industry Trends
  2. 2.2 Asthma Treatment Drugs Industry Drivers
  3. 2.3 Asthma Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Asthma Treatment Drugs Industry Restraints
3 Asthma Treatment Drugs Market by Manufacturers
  1. 3.1 Global Asthma Treatment Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Asthma Treatment Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Asthma Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Asthma Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Asthma Treatment Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Asthma Treatment Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Asthma Treatment Drugs Market by Type
  1. 4.1 Asthma Treatment Drugs Type Introduction
  2. 4.1.1 Long-term Control Medications
  3. 4.1.2 Quick-relief Medications (Rescue Medications)
  4. 4.1.3 Medications for Allergy-induced Asthma
  5. 4.2 Global Asthma Treatment Drugs Sales by Type
  6. 4.2.1 Global Asthma Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Asthma Treatment Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Asthma Treatment Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Asthma Treatment Drugs Revenue by Type
  10. 4.3.1 Global Asthma Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Asthma Treatment Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Asthma Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Asthma Treatment Drugs Market by Application
  1. 5.1 Asthma Treatment Drugs Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Asthma Treatment Drugs Sales by Application
  6. 5.2.1 Global Asthma Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Asthma Treatment Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Asthma Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Asthma Treatment Drugs Revenue by Application
  10. 5.3.1 Global Asthma Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Asthma Treatment Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Asthma Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Asthma Treatment Drugs Sales by Region
  1. 6.1 Global Asthma Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Treatment Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Asthma Treatment Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Asthma Treatment Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Asthma Treatment Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Asthma Treatment Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Asthma Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Asthma Treatment Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Asthma Treatment Drugs Revenue by Region
  1. 7.1 Global Asthma Treatment Drugs Revenue by Region
  2. 7.1.1 Global Asthma Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Asthma Treatment Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Asthma Treatment Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Asthma Treatment Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Asthma Treatment Drugs Revenue (2021-2032)
  8. 7.2.2 North America Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Asthma Treatment Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Asthma Treatment Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Asthma Treatment Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Asthma Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Asthma Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Asthma Treatment Drugs Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Asthma Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Asthma Treatment Drugs Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Asthma Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Asthma Treatment Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Asthma Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Asthma Treatment Drugs Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Asthma Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Asthma Treatment Drugs Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Roche & Novartis
  32. 8.6.1 Roche & Novartis Company Information
  33. 8.6.2 Roche & Novartis Business Overview
  34. 8.6.3 Roche & Novartis Asthma Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roche & Novartis Asthma Treatment Drugs Product Portfolio
  36. 8.6.5 Roche & Novartis Recent Developments
  37. 8.7 Boehringer Ingelheim
  38. 8.7.1 Boehringer Ingelheim Company Information
  39. 8.7.2 Boehringer Ingelheim Business Overview
  40. 8.7.3 Boehringer Ingelheim Asthma Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Boehringer Ingelheim Asthma Treatment Drugs Product Portfolio
  42. 8.7.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Treatment Drugs Value Chain Analysis
  2. 9.1.1 Asthma Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Treatment Drugs Production Mode & Process
  6. 9.2 Asthma Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Treatment Drugs Distributors
  9. 9.2.3 Asthma Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst